Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

November 01, 2015; Volume 88,Issue 5

Minireview

  • You have access
    Cyclin-Dependent Kinase Inhibitors as Anticancer Therapeutics
    Mary E. Law, Patrick E. Corsino, Satya Narayan and Brian K. Law
    Molecular Pharmacology November 2015, 88 (5) 846-852; DOI: https://doi.org/10.1124/mol.115.099325

Articles

  • Structural Asymmetry of Phosphodiesterase-9A and a Unique Pocket for Selective Binding of a Potent Enantiomeric Inhibitor
    You have access
    Structural Asymmetry of Phosphodiesterase-9A and a Unique Pocket for Selective Binding of a Potent Enantiomeric Inhibitor
    Manna Huang, Yongxian Shao, Jianying Hou, Wenjun Cui, Beibei Liang, Yingchun Huang, Zhe Li, Yinuo Wu, Xinhai Zhu, Peiqing Liu, Yiqian Wan, Hengming Ke and Hai-Bin Luo
    Molecular Pharmacology November 2015, 88 (5) 836-845; DOI: https://doi.org/10.1124/mol.115.099747
  • You have access
    Critical Cysteine Residues in Both the Calcium-Sensing Receptor and the Allosteric Activator AMG 416 Underlie the Mechanism of Action
    Shawn T. Alexander, Thomas Hunter, Sarah Walter, Jin Dong, Derek Maclean, Amos Baruch, Raju Subramanian and James E. Tomlinson
    Molecular Pharmacology November 2015, 88 (5) 853-865; DOI: https://doi.org/10.1124/mol.115.098392
  • You have access
    Mechanism of Modification, by Lidocaine, of Fast and Slow Recovery from Inactivation of Voltage-Gated Na+ Channels
    Vaibhavkumar S. Gawali, Peter Lukacs, Rene Cervenka, Xaver Koenig, Lena Rubi, Karlheinz Hilber, Walter Sandtner and Hannes Todt
    Molecular Pharmacology November 2015, 88 (5) 866-879; DOI: https://doi.org/10.1124/mol.115.099580
  • You have access
    α-Conotoxins Identify the α3β4* Subtype as the Predominant Nicotinic Acetylcholine Receptor Expressed in Human Adrenal Chromaffin Cells
    Arik J. Hone, J. Michael McIntosh, Layla Azam, Jon Lindstrom, Linda Lucero, Paul Whiteaker, Juan Passas, Jesús Blázquez and Almudena Albillos
    Molecular Pharmacology November 2015, 88 (5) 881-893; DOI: https://doi.org/10.1124/mol.115.100982
  • You have access
    Selectivity in the Use of Gi/o Proteins Is Determined by the DRF Motif in CXCR6 and Is Cell-Type Specific
    Satya P. Singh, John F. Foley, Hongwei H. Zhang, Darrell E. Hurt, Jennifer L. Richards, Craig S. Smith, Fang Liao and Joshua M. Farber
    Molecular Pharmacology November 2015, 88 (5) 894-910; DOI: https://doi.org/10.1124/mol.115.099960
  • You have access
    GPR139, an Orphan Receptor Highly Enriched in the Habenula and Septum, Is Activated by the Essential Amino Acids l-Tryptophan and l-Phenylalanine
    Changlu Liu, Pascal Bonaventure, Grace Lee, Diane Nepomuceno, Chester Kuei, Jiejun Wu, Qingqin Li, Victory Joseph, Steven W. Sutton, William Eckert, Xiang Yao, Lynn Yieh, Curt Dvorak, Nicholas Carruthers, Heather Coate, Sujin Yun, Christine Dugovic, Anthony Harrington and Timothy W. Lovenberg
    Molecular Pharmacology November 2015, 88 (5) 911-925; DOI: https://doi.org/10.1124/mol.115.100412
  • You have access
    Breathing Stimulant Compounds Inhibit TASK-3 Potassium Channel Function Likely by Binding at a Common Site in the Channel Pore
    Rikki H. Chokshi, Aaron T. Larsen, Brijesh Bhayana and Joseph F. Cotten
    Molecular Pharmacology November 2015, 88 (5) 926-934; DOI: https://doi.org/10.1124/mol.115.100107
  • You have access
    Identification of a Highly Conserved Allosteric Binding Site on Mnk1 and Mnk2
    Sunita K.C. Basnet, Sarah Diab, Raffaella Schmid, Mingfeng Yu, Yuchao Yang, Todd Alexander Gillam, Theodosia Teo, Peng Li, Tom Peat, Hugo Albrecht and Shudong Wang
    Molecular Pharmacology November 2015, 88 (5) 935-948; DOI: https://doi.org/10.1124/mol.115.100131
  • You have access
    Gedunin Binds to Myeloid Differentiation Protein 2 and Impairs Lipopolysaccharide-Induced Toll-Like Receptor 4 Signaling in Macrophages
    Perla Villani Borges, Katelim Hottz Moret, Clarissa Menezes Maya-Monteiro, Franklin Souza-Silva, Carlos Roberto Alves, Paulo Ricardo Batista, Ernesto Raúl Caffarena, Patrícia Pacheco, Maria das Graças Henriques and Carmen Penido
    Molecular Pharmacology November 2015, 88 (5) 949-961; DOI: https://doi.org/10.1124/mol.115.098970

Erratum

  • You have access
    Correction to “Gα13/PDZ-RhoGEF/RhoA Signaling Is Essential for Gastrin-Releasing Peptide Receptor–Mediated Colon Cancer Cell Migration”
    Molecular Pharmacology November 2015, 88 (5) 880; DOI: https://doi.org/10.1124/mol.115.093914err
Back to top
PreviousNext

In this issue

Molecular Pharmacology: 88 (5)
Molecular Pharmacology
Vol. 88, Issue 5
1 Nov 2015
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Minireview
  • Articles
  • Erratum
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics